|Podcasts|March 17, 2022
The Art of Science
Author(s)Elaine Quilici, Miranda Schmalfuhs
In episode 104, Susanne Schaffert, president of Novartis Oncology, discusses her career journey, which has combined both a passion for the arts and science, and how she believes the two can work together in pharma.
Advertisement
In episode 104, Susanne Schaffert, president of Novartis Oncology, discusses her career journey, which has combined both a passion for the arts and science, and how she believes the two can work together in pharma.
You can listen and/or download the episode on SoundCloud, or directly through iTunes, GooglePlay, Stitcher, and Overcast.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk’s Wegovy Pill Becomes First Oral GLP-1 Available in U.S.
2
Parental Control: Why Pharma’s Strongest Asset May Be Its Parent Brand
3
Ketamine’s Regulatory Reckoning: From Rapid Growth to Enforcement
4
Amgen Acquires Dark Blue Therapeutics in $840 Million Transaction
5